SARS-COV-2 S Trimer Protein (BA.2, HEK293, His)

Customer Review

Based on 1 Customer Validation

The SARS-CoV-2 S glycoprotein is critical in infection, binding to the ACE2 receptor and allowing viral particles to attach to the host cell membrane. Cleavage of S2/S2′ triggers cell membrane fusion or internalization via endocytosis. SARS-COV-2 S trimer Protein (BA.2, HEK293, His) is the recombinant virus-derived SARS-COV-2 S trimer protein, expressed by HEK293, with C-His labeled tag, mutations, and furin cleavage site mutants.

For research use only. We do not sell to patients.
  • Species: Virus
  • Source: HEK293
  • Storage:
    Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • Help & FAQs

Biological Activity

Description

The SARS-CoV-2 S glycoprotein is critical in infection, binding to the ACE2 receptor and allowing viral particles to attach to the host cell membrane. Cleavage of S2/S2′ triggers cell membrane fusion or internalization via endocytosis. SARS-COV-2 S trimer Protein (BA.2, HEK293, His) is the recombinant virus-derived SARS-COV-2 S trimer protein, expressed by HEK293, with C-His labeled tag, mutations, and furin cleavage site mutants.

Background

The SARS-CoV-2 S glycoprotein plays a crucial role in infection by attaching the virion to the host cell membrane through interaction with the primary receptor, host ACE2. Upon cleavage of S2/S2', binding to the ACE2 receptor initiates either direct fusion at the cell membrane or internalization of the virus via endocytosis, leading to fusion of the virion membrane with the host endosomal membrane. Additionally, the glycoprotein may utilize NRP1/NRP2 and integrin as alternative entry receptors, possibly explaining the virus's tropism in human olfactory epithelial cells. The stalk domain of S exhibits three hinges, providing unexpected orientational freedom to the head. Acting as a class I viral fusion protein, the glycoprotein undergoes an extensive and irreversible conformational change during virus entry, triggered by host TMPRSS2 or CSTL, leading to fusion of the viral envelope with the cellular cytoplasmic membrane and release of viral genomic RNA into the host cell cytoplasm. The glycoprotein exhibits at least three conformational states: pre-fusion native, pre-hairpin intermediate, and post-fusion hairpin, with the coiled coil regions adopting a trimer-of-hairpins structure during fusion, facilitating the apposition and subsequent fusion of viral and target cell membranes.

Verified Bioactivity

Immobilized ACE2 Protein, Human, Recombinant (mFc Tag) at 2 μg/mL (100 μL/well) can bind SARS-CoV 2 (BA.2) Spike S1+S2 trimer Protein (ECD, His Tag), the EC50 is 11.3ng/mL

Technical Parameters

  • Species Virus
  • Source HEK293
  • Tag C-His
  • Accession
  • Gene ID
  • Molecular Construction
    • N-term
    • Spike Trimer (V16-Q1208, with multiple mutations)
      Accession # P0DTC2/YP_009724390.1
    • T4 fibritin trimerization motif-10*His
    • C-term
  • Protein Length

    Partial Extracellular Domain

  • Mutation

    T19I, L24S, ΔP25-A27, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, S477N, T478K, E484A, Q493R, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H, N969K; R682G, R683S, R685S; F817P, A892P, A899P, A942P, K986P, V987P

  • Mutation Definition

    T19I, L24S, ΔP25-A27, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, S477N, T478K, E484A, Q493R, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H, N969K: SARS-CoV-2 Omicron BA.2 variant-associated mutations (Pango lineage BA.2);
    R682G, R683S, R685S: Furin cleavage site ablation;
    F817P, A892P, A899P, A942P, K986P, V987P: Prefusion trimer stabilization

  • Synonyms

    S protein; Spike glycoprotein; S glycoprotein; COVID-19; BA.2

  • Predicted Molecular Mass

    136.5 kDa

  • Molecular Weight

    Approximately 150-200 kDa, based on SDS-PAGE under reducing conditions.

  • Purity

    ≥ 90%, as determined by reducing SDS-PAGE.

Product Properties

Appearance

Solution

Formulation

Supplied as a 0.2 μm filtered solution of sodium citrate buffer system, pH 6.0.

Endotoxin Level

<1 EU/μg, determined by LAL method.

Storage & Stability

Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.

Shipping

Shipping with dry ice.

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00